Vitalhub (TSE:VHI - Get Free Report) received a C$14.00 price target from Scotiabank in a research note issued on Thursday, MarketBeat.com reports. The brokerage currently has an "outperform" rating on the stock. Scotiabank's price objective points to a potential upside of 24.78% from the company's current price.
Several other research analysts also recently commented on the stock. TD Securities raised shares of Vitalhub to a "strong-buy" rating in a research note on Monday, November 25th. Cormark boosted their price objective on shares of Vitalhub from C$9.50 to C$10.50 and gave the company a "buy" rating in a research report on Wednesday, October 2nd. Finally, Canaccord Genuity Group boosted their target price on shares of Vitalhub from C$12.00 to C$12.50 and gave the company a "buy" rating in a report on Thursday, January 16th. Five research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus target price of C$10.71.
Check Out Our Latest Stock Analysis on Vitalhub
Vitalhub Trading Down 1.6 %
Shares of VHI stock traded down C$0.18 during trading hours on Thursday, hitting C$11.22. 155,832 shares of the company's stock were exchanged, compared to its average volume of 132,566. The company has a market capitalization of C$570.54 million, a PE ratio of 102.00, a PEG ratio of 1.18 and a beta of 1.26. Vitalhub has a 12-month low of C$4.64 and a 12-month high of C$12.09. The business's 50 day simple moving average is C$11.30 and its 200-day simple moving average is C$9.71.
About Vitalhub
(
Get Free Report)
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Featured Articles
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
